ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Bisoprolol-Mepha Tabletten:Mepha Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
C07AB07 - BisoprololATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
 
C07 - Beta Blocking Agents
 
C07A - Beta Blocking Agents

All plain beta blocking agents are classified in this group. Combination packages containing two different products (e.g. sotalol tablets and aspirin tablets in a combination package) are also classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.
The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.

C07AB - Beta Blocking Agents, Selective

All plain selective beta blocking agents are classified in this group.
The s-enantiomer and the racemate of atenolol are classified at separate 5th levels.

Different DDDs have been assigned for the two stereoisomeric forms of atenolol due to different potency.

C07AB07 - Bisoprolol
DoseRoute of administrationNote
10 mgO 
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home